West Pharmaceutical Services, Inc

Medical Supplies
WST
$ 304 0.3
Share price
$ 23 bn
Market Cap
$ 23 bn
Enterprise Value

Carbon footprint

5.3 Ton
GHG emissions per $ 1 mln investment
0.19x the weighted average for S&P 500
FY2020
How is this calculated?
-1.1%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-3%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

West Pharmaceutical Services, Inc aims to reduce Scope 1 + 2 by 10% by 2023 from a base year 2019


This target has not been verified as science based according to SBTi
West Pharmaceutical Services, Inc's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

West Pharmaceutical Services, Inc's GHG emissions (location-based) (Kt of CO2e)
West Pharmaceutical Services, Inc's Carbon intensity (Tons per 1 USDm)

West Pharmaceutical Services, Inc's carbon footprint

West Pharmaceutical Services, Inc reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 121 Kt (-1.3 /-1.1% y-o-y). Also positively, carbon intensity declined to 56 t (-10 /-15.2% y-o-y).

No public disclosure of Scope 3 emissions has been found for West Pharmaceutical Services, Inc at the moment.

The company is committed to reducing Scope 1 + 2 by 10% by 2023 from a base year 2019, which translates into the estimated reduction of -3.6 Kt per annum over the period of FY2021 - FY2023. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...